The study of phosphorylated OLIG2 applies proteomics methods to reveal that glioma cells will have a stronger invasive mesenchymal character with the induction of non-phosphorylated OLIG2 to activate TGF-b2, providing a mechanistic insight for the transformation of cells from proliferation to invasion (22). Here, OLIG2 is linked to central nervous system cancer.